Status:

UNKNOWN

Individualised Weaning From Mechanical Ventilation in General ICU

Lead Sponsor:

Chelsea and Westminster NHS Foundation Trust

Collaborating Sponsors:

Aalborg University

Conditions:

Ventilatory Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Patients residing in the intensive care unit typically receive mechanical ventilatory support. Selecting the appropriate level of mechanical ventilation is not trivial, and it has been shown that lung...

Detailed Description

All patients admitted to the ICU with mechanical ventilation are screened for inclusion. Patients receiving invasive mechanical ventilation (≥ 24 h) will be considered for inclusion in the study on a ...

Eligibility Criteria

Inclusion

  • Patient is expected to be on invasive mechanical ventilation more 24 hours.
  • Age \> 18 years
  • Haemodynamically stable (with instability defined by the presence of two or more of the following criteria: acidosis pH \< 7.2, poor urine output \< 0.5ml/kg, use of vasopressors, e.g. noradrenline \> 25 μg/min).
  • Patient consent or, in the case that the patient is unable, assent from the next of kin or treating physician following understanding and accept of oral and written information describing the study

Exclusion

  • The absence of an arterial catheter for blood sampling at study start.
  • Medical history of home mechanical ventilation which may lead to prolonged stay in the ICU, including long term oxygen therapy and non-invasive ventilation not associated with sleep apnoa.
  • Clinical conditions requiring treatment with extracorporeal membrane oxygenation, i.e. an inspired oxygen of 100% for more than 24 hours.
  • Head trauma or other conditions where intra-cranial pressure may be elevated and tight regulation of arterial CO2 level is paramount.
  • Primary neurological patients (Glasgow coma score \<10, neurologic damage with limited prognosis, stroke hemiplegia).
  • Severe heart failure, classified as grade 4 of the Association of Cardiology guidelines \[2\].
  • End stage liver disease.
  • Multiple medical ICU admissions, i.e. more than one admission.
  • Corrective orthognathic surgery.
  • Esophageal surgery.
  • Morbidly obese patients defined as either BMI\>45, or 35\<BMI\<45 with APACHEII score on admission greater than 24.
  • Pregnancy.
  • Mechanical ventilation initiated for more for 24 hours in other centers

Key Trial Info

Start Date :

December 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2021

Estimated Enrollment :

274 Patients enrolled

Trial Details

Trial ID

NCT03249623

Start Date

December 11 2017

End Date

July 30 2021

Last Update

July 21 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Magill Department of Anaesthesia, Chelsea and Westminster Hospital

London, United Kingdom, SW10 9NH